White Paper on Contribution of Nanomedicine to Horizon 2020

The ETPN and the NANOMED2020 CSA announce the publication of a White Paper providing key recommendations for the European Commission and the EU Member States to create a favourable ecosystem for the successful deployment of Nanomedicine in Europe. It lays thereby the groundwork to manage the efficient translation of nanotechnology from a KET into new and innovative medical product.

Pays

Austria, Belgium, Bulgaria, Cyprus, Czechia, Germany, Denmark, Estonia, Greece, Spain, Finland, France, Hungary, Ireland, Italy, Lithuania, Luxembourg, Latvia, Malta, Netherlands, Poland, Portugal, Romania, Sweden, Slovenia, Slovakia, United Kingdom